Meropenem Prevents Levofloxacin-Induced Resistance in Penicillin-Resistant Pneumococci and Acts Synergistically with Levofloxacin in Experimental Meningitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 11, 2003, Pages 656-662

  Cottagnoud, P ^a   Cottagnoud, M ^b   Acosta, F ^b   Flatz, L ^b   Kuhn F ^b   Stucki, A ^a   Entenza, J ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Spital Bern Ziegler ^*  (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GARENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PENICILLIN DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID ANALYSIS; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; GENE MUTATION; GENETIC CODE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANT PNEUMOCOCCUS; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; RABBITS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; THIENAMYCINS;

EID: 0345375573     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-1016-1     Document Type: Article

References (26)

1. Jacobs MR (1999) Emergence of antibiotic resistance in upper and lower respiratory tract infections. Am J Manag Care 5 [Suppl]:651-661
2. Davies TA, Evangelista A, Pfleger S, Bush K, Sahm DF, Goldschmidt R (2002) Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000. Antimicrob Agents Chemother 46:119-124
3. Chen DK, McGeer A, Azavedo JC de, Low DE (1999) Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 341:233-239
4. Schmitz FJ, Fisher A, Boos M, Mayer S, Milatovic D, Fluit AC (2001) Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 20:219-222
5. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, Azavedo JC de, Kibsey P, Fleming C, Low DE (2002) Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 346:747-750
6. Kaplan SL, Mason EO Jr (1998) Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 11:628-644
7. McCullers JA, English BK, Novak R (2000) Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 181:369-373
8. Gerber CM, Cottagnoud M, Neftel KA, Tauber MG, Cottagnoud P (1999) Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain. Eur J Clin Microbiol Infect Dis 18:866-870
9. Dacey RG, Sande MA (1974) Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 6:437-441
10. Nau R, Kaye K, Sachdeva M, Sande ER, Tauber MG (1994) Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother 38:1186-1189
11. Simon HJ, Yin EJ (1970) Microbioassay of antimicrobial agents. Appl Microbiol 19:573-579
12. Lack S, Hotchkiss RD (1960) A study of genetic material determining an enzyme activity in pneumococcus. Biochem Biophys Acta 39:508-518
13. Cottagnoud P, Acosta F, Cottagnoud M, Neftel K, Tauber MG (2000) Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrob Agents Chemother 44:2179-2181
14. Eliopoulos GM, Moellering RC (1996) Antimicrobial combinations. In: Loarina V (ed.) Antibiotics in laboratory medicine, 4th edn. Williams & Wilkins, Baltimore, pp 330-396
15. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P (1997) Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother 41:1662-1667
16. Sambrook J, Fritsch F, Manaiatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
17. Pan XS, Fisher LM (1996) Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J Bacteriol 178:4060-4069
18. Gerber CM, Cottagnoud M, Neftel K, Tauber MG, Cottagnoud P (2000) Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. J Antimicrob Chemother 45:63-68
19. Cottagnoud P, Entenza JM, Cottagnoud M, Que YA, Moreillon P, Tauber MG (2001) Subinhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae. BMC Microbiol 1:9
20. Gootz TD, Zaniewski R, Haskell S, Schmieder B, Tankovic J, Girard D, Courvalin P, Polzer RJ (1996) Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrob Agents Chemother 40:2691-2697
21. Munoz R, De La Campa AG (1996) ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob Agents Chemother 40:2252-2257
22. Tankovic J, Perichon B, Duval J, Courvalin P (1996) Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob Agents Chemother 40:2505-2510
23. Dagan R, Velghe L, Rodda JL, Klugman KP (1994) Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother 34:175-179
24. Scotton PG, Pea F, Giobbia M, Baraldo M, Vaglia A, Furlanut M (2001) Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. Clin Infect Dis 33:109-111
25. Nau R, Schmidt T, Kaye K, Froula JL, Tauber MG (1995) Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother 39:593-597
26. Rodoni D, Hanni F, Gerber CM, Cottagnoud M, Neftel K, Tauber MG, Cottagnoud P (1999) Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model. Antimicrob Agents Chemother 43:963-965